Publications by authors named "Markus Pfirrmann"

43Publications

The proportion of different BCR-ABL1 transcript types in chronic myeloid leukemia. An international overview.

Leukemia 2019 05 23;33(5):1173-1183. Epub 2019 Jan 23.

Institut für Medizinische Informationsverarbeitung, Biometrie und Epidemiologie (IBE), Ludwig-Maximilians-Universität München, Munich, Germany.

View Article

Download full-text PDF

Source
http://www.nature.com/articles/s41375-018-0341-4
Publisher Site
http://dx.doi.org/10.1038/s41375-018-0341-4DOI Listing
May 2019

Imatinib dose reduction in major molecular response of chronic myeloid leukemia: results from the German Chronic Myeloid Leukemia-Study IV.

Haematologica 2019 05 4;104(5):955-962. Epub 2018 Dec 4.

Institut für Medizinische Informationsverarbeitung, Biometrie und Epidemiologie, Ludwig-Maximilians-Universität München, Munich, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3324/haematol.2018.206797DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6518910PMC
May 2019

Efficacy of vildagliptin for prevention of postpartum diabetes in women with a recent history of insulin-requiring gestational diabetes: A phase II, randomized, double-blind, placebo-controlled study.

Mol Metab 2018 03 3;9:168-175. Epub 2018 Jan 3.

Forschergruppe Diabetes e.V. am Helmholtz Zentrum München, Ingolstädter Landstr. 1, 85764 Neuherberg, Germany; Institute of Diabetes Research, Helmholtz Zentrum München, and Forschergruppe Diabetes, Klinikum rechts der Isar, Technische Universität München, Ingolstädter Landstr. 1, 85764 Neuherberg, Germany. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.molmet.2017.12.015DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5869734PMC
March 2018

Smokers with chronic myeloid leukemia are at a higher risk of disease progression and premature death.

Cancer 2017 Jul 13;123(13):2467-2471. Epub 2017 Feb 13.

Institute for Medical Information Sciences, Biometry, and Epidemiology (IBE), Ludwig-Maximilians University, Munich, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cncr.30636DOI Listing
July 2017

Prognostic scores for patients with chronic myeloid leukemia under particular consideration of competing causes of death.

Ann Hematol 2015 Apr 27;94 Suppl 2:S209-18. Epub 2015 Mar 27.

Institut für Medizinische Informationsverarbeitung, Biometrie und Epidemiologie-IBE, Ludwig-Maximilians-Universität, Marchioninistraße 15, 81377, München, Germany,

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00277-015-2316-0DOI Listing
April 2015

A multi-state model approach for prediction in chronic myeloid leukaemia.

Ann Hematol 2015 Jun 3;94(6):919-27. Epub 2014 Dec 3.

Institut für medizinische Informationsverarbeitung, Biometrie und Epidemiologie, Ludwig-Maximilians-Universität, Marchioninistr. 15, 81377, München, Germany,

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00277-014-2246-2DOI Listing
June 2015

Equivalence of BCR-ABL transcript levels with complete cytogenetic remission in patients with chronic myeloid leukemia in chronic phase.

J Cancer Res Clin Oncol 2014 Nov 22;140(11):1965-9. Epub 2014 Jun 22.

Institut für Medizinische Informationsverarbeitung, Biometrie und Epidemiologie, Ludwig-Maximilians-Universität, Munich, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00432-014-1746-8DOI Listing
November 2014

The impact of health care settings on survival time of patients with chronic myeloid leukemia.

Blood 2014 Apr 12;123(16):2494-6. Epub 2014 Mar 12.

Institut für Medizinische Informationsverarbeitung, Biometrie und Epidemiologie, Ludwig-Maximilians-Universität, München, Germany; and.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/blood-2013-11-539742DOI Listing
April 2014

Deep molecular response is reached by the majority of patients treated with imatinib, predicts survival, and is achieved more quickly by optimized high-dose imatinib: results from the randomized CML-study IV.

J Clin Oncol 2014 Feb 2;32(5):415-23. Epub 2013 Dec 2.

Rüdiger Hehlmann, Martin C. Müller, Benjamin Hanfstein, Alice Fabarius, Annette Schreiber, Ulrike Proetel, Nadine Pletsch, Susanne Saußele, Universitätsmedizin Mannheim Medizinische Fakultät Mannheim der Universität Heidelberg, Mannheim; Jolanta Dengler Universitätsklinikum Heidelberg, Heidelberg; Michael Lauseker, Markus Pfirrmann, Joerg Hasford, Institut für Medizinische Informationsverarbeitung, Biometrie und Epidemiologie (IBE), Ludwig-Maximilians-Universität; Christoph Nerl, Städtisches Klinikum Munchen Schwabing; Hans-Jochem Kolb, Klinikum rechts der Isar, Technische Universität München; Karsten Spiekermann, Universitätsklinikum, Ludwig-Maximilians Universität München; Claudia Haferlach, Susanne Schnittger, MLL Münchner Leukämielabor, Munich; Hermann Einsele, Universitätsklinikum Würzburg, Würzburg; Christiane Falge, Klinikum Nürnberg Nord, Nuremberg; Lothar Kanz, Universitätsklinikum Tübingen, Tübingen; Andreas Neubauer, Universitätsklinikum Gießen und Marburg, Marburg; Michael Kneba, Universitätsklinikum Schleswig-Holstein, Kiel; Frank Stegelmann, Hermann Heimpel, Universitätsklinikum Ulm, Ulm; Michael Pfreundschuh, Universitätsklinikum des Saarlandes, Homburg/Saar; Cornelius F. Waller, Universitätsklinikum Freiburg, Freiburg; Gerhard Ehninger, Universitätsklinikum Carl Gustav Carus, Dresden; Stefan W. Krause, Universitätsklinikum Erlangen, Erlangen; Dieter K. Hossfeld, Universitätsklinikum Eppendorf, Hamburg; Andreas Hochhaus, Universitätsklinikum Jena, Jena, Germany; Gabriela M. Baerlocher, Inselspital Bern, Bern; Dominik Heim, Universitätsspital Basel, Basel, Switzerland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2013.49.9020DOI Listing
February 2014

Clinical trials in chronic myeloid leukemia.

Curr Hematol Malig Rep 2012 Jun;7(2):109-15

Universitätsmedizin Mannheim, Universität Heidelberg, III. Medizinische Klinik, Mannheim, Germany.

View Article

Download full-text PDF

Source
http://link.springer.com/10.1007/s11899-012-0118-1
Publisher Site
http://dx.doi.org/10.1007/s11899-012-0118-1DOI Listing
June 2012

Prediction of post-remission survival in acute myeloid leukaemia: a post-hoc analysis of the AML96 trial.

Lancet Oncol 2012 Feb 22;13(2):207-14. Epub 2011 Dec 22.

Institut für Medizinische Informationsverarbeitung, Biometrie und Epidemiologie-IBE, Ludwig-Maximilians-Universität, Munich, Germany.

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S14702045117032
Publisher Site
http://dx.doi.org/10.1016/S1470-2045(11)70326-6DOI Listing
February 2012

Shedding of the endothelial glycocalyx during cardiac surgery: on-pump versus off-pump coronary artery bypass graft surgery.

J Thorac Cardiovasc Surg 2009 Dec 4;138(6):1445-7. Epub 2009 Feb 4.

Clinic of Anesthesiology, Ludwig-Maximilians-University, Munich, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jtcvs.2008.07.063DOI Listing
December 2009

Heterogeneous prognostic impact of derivative chromosome 9 deletions in chronic myelogenous leukemia.

Blood 2007 Aug 24;110(4):1283-90. Epub 2007 Apr 24.

Wessex Regional Genetics Laboratory, University of Southampton, Salisbury, United Kingdom.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/blood-2007-02-074252DOI Listing
August 2007